Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2187150 | 0.81 | EPHX1 (0.52) | MEN1KMT2AEPHX1ALDH1A1 | |
| SCHEMBL13917138 | 0.73 | SLC6A4 (0.48) | MEN1KMT2AEPHX1RAB9ANPC1 | |
| SCHEMBL13326288 | 0.73 | SLC6A4 (0.48) | MEN1KMT2AEPHX1RAB9ANPC1 | |
| SCHEMBL102353 | 0.73 | MEN1 (0.63) | MEN1KMT2AEPHX1RAB9ANPC1 | |
| SCHEMBL2190926 | 0.72 | KMT2A (0.40) | MEN1KMT2AEPHX1KDM4EALDH1A1 | |
| SCHEMBL6758772 | 0.68 | ALDH1A1 (0.52) | MEN1KMT2AEPHX1ALDH1A1 | |
| SCHEMBL27728485 | 0.68 | ALDH1A1 (0.58) | MEN1KMT2ANPC1ALDH1A1POLB | |
| SCHEMBL292812 | 0.67 | ALDH1A1 (0.57) | MEN1KMT2ANPC1KDM4EALDH1A1 | |
| SCHEMBL101961 | 0.67 | KMT2A (0.58) | MEN1KMT2AEPHX1RAB9ANPC1 | |
| SCHEMBL28718046 | 0.67 | ALDH1A1 (0.57) | MEN1KMT2ANPC1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090305437-A1 | FABRICATION OF INORGANIC MATERIALS USING TEMPLATES WITH LABILE LINKAGE | CAMBRIOS TECHNOLOGIES CORPORATION (US) | 2009-12-10 | — | — | US | disclosed |
| WO-2007103539-A2 | FABRICATION OF INORGANIC MATERIALS USING TEMPLATES WITH LABILE LINKAGE | CAMBRIOS TECHNOLOGIES CORPORATION (US) | 2007-09-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090305437-A1 | FABRICATION OF INORGANIC MATERIALS USING TEMPLATES WITH LABILE LINKAGE | ILK, ECPAS, STUB1 | MEN1 481/4885KMT2A 1539/4885EPHX1 2467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.